SS
State Street Corp disclosed a 5.2% stake in SNDX
State Street Corp reported owning 5.2% of Syndax Pharmaceuticals Inc (SNDX) (4,653,172 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G